NervGen Pharma Corp (NGEN) — Long-term Investment Intensity
NervGen Pharma Corp (NGEN) has a Long-term Investment Intensity of 0.0% as of December 2024. Long-term investments of CA$8.37K represent 0.0% of total assets of CA$19.49 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore NervGen Pharma Corp operating cash flow efficiency to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
NervGen Pharma Corp Long-term Investment Intensity (2024–2024)
This chart shows how NervGen Pharma Corp's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the intensity stands at 0.0%, reflecting long-term investments of CA$8.37K against total assets of CA$19.49 Million CAD. Explore NervGen Pharma Corp (NGEN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for NervGen Pharma Corp (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for NervGen Pharma Corp from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NervGen Pharma Corp (NGEN) total market value.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.0% | CA$8.37K | CA$19.49 Million | — |